Loading chat...
OH HR428
Resolution
Status
5/24/2016
Primary Sponsor
Nickie Antonio
Click for details
AI Summary
-
American Cancer Society estimates approximately 1,685,210 new cancer cases will be diagnosed in 2016, with about 595,690 deaths expected that year
-
Direct medical costs of cancer were nearly $125 billion in 2013 and are projected to reach at least $158 billion by 2020
-
Global spending on cancer drugs increased from $37 billion a decade ago to $91 billion in 2013
-
Many insurance plans require cancer patients to pay 20% to 40% out-of-pocket costs for medications, and an estimated one in eight advanced cancer patients decline recommended care due to cost
-
Ohio House of Representatives urges Congress, the FDA, and the National Institutes of Health to address cancer drug cost and availability, with copies of the resolution to be sent to federal leadership
Legislative Description
To urge the Congress of the United States, the United States Food and Drug Administration, and the National Institutes of Health to address the cost and availability of cancer drugs.
Last Action
Introduced and Referred to Committee: Health and Aging
5/24/2016